These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6998350)

  • 1. [Recent data on somatomedins (insulin-like growth factors) (author's transl)].
    Binoux M
    Ann Endocrinol (Paris); 1980; 41(3):157-92. PubMed ID: 6998350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A personal view on the early history of the insulin-like growth factors.
    Van den Brande JL
    Horm Res; 1999; 51 Suppl 3():149-75. PubMed ID: 10592460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)].
    Froesch ER; Zapf J
    Ann Endocrinol (Paris); 1980; 41(6):502-11. PubMed ID: 7018376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts.
    Rechler MM; Nissley SP; Podskalny JM; Moses AC; Fryklund L
    J Clin Endocrinol Metab; 1977 May; 44(5):820-31. PubMed ID: 192752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NSILA, insulin-like growth factors and somatomedins (author's transl)].
    Froesch ER
    Schweiz Rundsch Med Prax; 1979 Mar; 68(13):412-6. PubMed ID: 432207
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiplication-stimulating activity (MSA): a somatomedin-like polypeptide from cultured rat liver cells.
    Nissley SP; Rechler MM
    Natl Cancer Inst Monogr; 1978 May; (48):167-77. PubMed ID: 748750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
    Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
    Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
    Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
    Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor I in cultured rat granulosa cells.
    Adashi EY; Resnick CE; Hernandez ER; Svoboda ME; Van Wyk JJ
    Endocrinology; 1988 Jan; 122(1):194-201. PubMed ID: 2961555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of somatomedin-A and -C, NSILA-S and insulin to human placental cell membranes.
    van Buul-Offers S; Van den Brande JL
    Horm Res; 1979; 11(4):186-202. PubMed ID: 227778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
    Van Wyk JJ; Svoboda ME; Underwood LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biosynthesis and hormonal regulation of IGF (insulin-like growth factors, or somatomedins). Experimental and clinical studies (author's transl)].
    Binoux M; Hossenlopp P; Gourmelen M; Girard F
    Ann Endocrinol (Paris); 1980; 41(6):487-94. PubMed ID: 7018374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of proinsulin with the insulin-like growth factor-I receptor in human liver, muscle, and adipose tissue.
    Burguera B; Frank BH; DiMarchi R; Long S; Caro JF
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1238-41. PubMed ID: 1851182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of human basic-somatomedin: comparison with insulin-like growth factors I and II.
    Bhaumick B; Goren HJ; Bala RM
    Horm Metab Res; 1981 Sep; 13(9):515-8. PubMed ID: 6271660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
    Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
    J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatomedins. Structure, physiology and clinical data].
    Van den Brande JL
    Ann Endocrinol (Paris); 1986; 47(5):350-62. PubMed ID: 2435221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin receptors-a review (author's transl)].
    Freychet P
    Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.